Equillium Inc

NASDAQ:EQ   11:20:02 AM EDT
+0.28 (+6.26%)
Other Pre-Announcement

Equillium Posts Q3 Loss Per Share Of $0.35

Published: 11/10/2021 21:45 GMT
Equillium Inc (EQ) - Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates.
Q3 Loss per Share $0.35.
Reaffirms Guidance for Equip Phase 1b Topline Data in Q4 2021.
Updates Guidance to Commence Acute Gvhd Pivotal Study in Early 2022.
Updates Guidance for Interim Data From Equalise Phase 1b Type B Lupus Nephritis Patients to Mid-2022.
Believes That Its Cash and Investments Will Be Sufficient to Fund Its Currently Planned Operations Into 2023.
Q3 Earnings per Share View $-0.34 -- Refinitiv Ibes Data (analyst estimates).